Tower Research Capital (TRC)’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-35,520
| Closed | -$43K | – | 6556 |
|
|
2023
Q1 | $43K | Buy |
35,520
+32,400
| +1,038% | +$72.1K | ﹤0.01% | 2647 |
|
|
2022
Q4 | $4K | Sell |
3,120
-6,660
| -68% | -$14.3K | ﹤0.01% | 5126 |
|
|
2022
Q3 | $24K | Sell |
9,780
-15,378
| -61% | -$51.3K | ﹤0.01% | 3800 |
|
|
2022
Q2 | $57K | Buy |
25,158
+17,578
| +232% | +$65.5K | ﹤0.01% | 2770 |
|
|
2022
Q1 | $51K | Buy |
7,580
+6,569
| +650% | +$56.2K | ﹤0.01% | 2722 |
|
|
2021
Q4 | $10K | Sell |
1,011
-11,636
| -92% | -$108K | ﹤0.01% | 4641 |
|
|
2021
Q3 | $128K | Buy |
12,647
+2,908
| +30% | +$31.9K | ﹤0.01% | 2198 |
|
|
2021
Q2 | $125K | Sell |
9,739
-2,338
| -19% | -$32.1K | ﹤0.01% | 2248 |
|
|
2021
Q1 | $171K | Sell |
12,077
-1,972
| -14% | -$27.2K | ﹤0.01% | 2147 |
|
|
2020
Q4 | $149K | Sell |
14,049
-86,897
| -86% | -$789K | ﹤0.01% | 1989 |
|
|
2020
Q3 | $772K | Buy |
100,946
+77,303
| +327% | +$569K | 0.01% | 1226 |
|
|
2020
Q2 | $143K | Buy |
+23,643
| New | +$117K | 0.01% | 2127 |
|
|
2020
Q1 | – | Sell |
-1,044
| Closed | -$11K | – | 4171 |
|
|
2019
Q4 | $11K | Buy |
+1,044
| New | +$9.27K | ﹤0.01% | 2304 |
|
|
2019
Q3 | – | Sell |
-5,480
| Closed | -$50K | – | 4659 |
|
|
2019
Q2 | $50K | Buy |
+5,480
| New | +$57.2K | ﹤0.01% | 1578 |
|
|
2018
Q3 | – | Sell |
-3,557
| Closed | -$43K | – | 4383 |
|
|
2018
Q2 | $43K | Buy |
3,557
+1,351
| +61% | +$18.1K | ﹤0.01% | 1933 |
|
|
2018
Q1 | $34K | Buy |
2,206
+1,661
| +305% | +$27.7K | ﹤0.01% | 1905 |
|
|
2017
Q4 | $9K | Sell |
545
-6,453
| -92% | -$125K | ﹤0.01% | 2639 |
|
|
2017
Q3 | $160K | Buy |
6,998
+3,884
| +125% | +$82.8K | 0.01% | 940 |
|
|
2017
Q2 | $87K | Sell |
3,114
-1,396
| -31% | -$38.6K | 0.01% | 550 |
|
|
2017
Q1 | $138K | Buy |
4,510
+2,379
| +112% | +$67.2K | 0.01% | 384 |
|
|
2016
Q4 | $54K | Buy |
2,131
+1,582
| +288% | +$37.3K | 0.01% | 1389 |
|
|
2016
Q3 | $14K | Sell |
549
-5,377
| -91% | -$143K | ﹤0.01% | 1847 |
|
|
2016
Q2 | $147K | Buy |
5,926
+5,678
| +2,290% | +$146K | 0.01% | 868 |
|
|
2016
Q1 | $7K | Sell |
248
-152
| -38% | -$3.97K | ﹤0.01% | 2428 |
|
|
2015
Q4 | $12K | Buy |
+400
| New | +$13.6K | ﹤0.01% | 1933 |
|
|
2015
Q1 | – | Sell |
-548
| Closed | -$19K | – | 5080 |
|
|
2014
Q4 | $19K | Buy |
548
+546
| +27,300% | +$19.3K | ﹤0.01% | 1648 |
|
|
2014
Q3 | $0 | Sell |
2
-4,265
| -100% | -$161K | ﹤0.01% | 5011 |
|
|
2014
Q2 | $171K | Buy |
+4,267
| New | +$164K | 0.02% | 659 |
|
|
2014
Q1 | – | Sell |
-608
| Closed | -$20K | – | 5077 |
|
|
2013
Q4 | $20K | Sell |
608
-867
| -59% | -$27K | ﹤0.01% | 2353 |
|
|
2013
Q3 | $44K | Buy |
1,475
+1,410
| +2,169% | +$44.2K | ﹤0.01% | 2027 |
|
|
2013
Q2 | $2K | Buy |
+65
| New | +$2.01K | ﹤0.01% | 3545 |
|
Other funds holding DBD
BFIM
HNB
Tower Research Capital (TRC)'s DBD Position: Q2 2023 in Review
Tower Research Capital (TRC) sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 35,520 shares — an estimated $43K sold.
Tower Research Capital (TRC) first reported a position in DBD in Q2 2013 and held it in 31 quarters. The position peaked at $772K in Q3 2020. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.
- Tower Research Capital (TRC) reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 35,520 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $43K.
- Tower Research Capital (TRC) first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 31 quarters.
- Tower Research Capital (TRC)'s Diebold Nixdorf Incorporated position peaked at $772K in Q3 2020.
- 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.